Optineurin Variants in Ghanaian Glaucoma Patients
Author Information
Author(s): Liu Yutao, Akafo Stephen, Santiago-Turla Cecile, Cohen Claudia S., LaRocque-Abramson Karen R., Qin Xuejun, Herndon Leon W., Challa Pratap, Schmidt Silke, Hauser Michael A., Allingham R. Rand
Primary Institution: Duke University Medical Center
Hypothesis
This study investigated the role of OPTN sequence variants in patients with primary open-angle glaucoma in Ghana.
Conclusion
The study suggests that coding variants in OPTN may not contribute to the risk for primary open-angle glaucoma in persons of West African descent.
Supporting Evidence
- Seven coding variants were identified in the OPTN gene.
- Three of the coding variants were novel and not previously reported.
- No significant differences in allele frequencies were found between POAG cases and controls.
Takeaway
Researchers looked at a gene called optineurin in people with glaucoma in Ghana and found that it doesn't seem to cause the disease in this group.
Methodology
A case-control study comparing 140 POAG patients with 130 non-glaucomatous controls, using PCR and sequencing to analyze OPTN variants.
Limitations
The study may not represent all populations, and the sample size, while large, may still miss rare variants.
Participant Demographics
Participants included unrelated Ghanaian POAG cases and non-glaucomatous controls, with a mean age of 63 years for cases and 59 years for controls.
Statistical Information
Statistical Significance
p>0.05
Want to read the original?
Access the complete publication on the publisher's website